臺灣博碩士論文加值系統

摘要
本實驗主要目的是探討傷寒草對口腔癌細胞的致死作用。論文中以口腔癌細胞(CT-5’)為實驗對象，探討傷寒草萃取物對口腔癌細胞的影響。利用各種的生物活性試驗方法，尋找傷寒草殺死口腔癌細胞(CT-5’)的可能機制。傷寒草(Vernonia cinerea)，又名「一支香」，屬於菊科(composiate)植物，花朵為略帶紫色的野草，分布於熱帶亞洲。台灣坊間將傷寒草以酒水蒸煮後食用，發現對治療喉癌，口腔癌症有一定的療效。
傷寒草經過50%酒精萃取濃縮後，進行細胞實驗，實驗結果中發現，將傷寒草全草濃縮液處理口腔癌細胞(CT-5’)24 hrs後，其LD50約為375 μg/cc。若將傷寒草莖葉經50% ETOH萃取濃縮後再以氯仿partition分層取有機層濃縮液，進行細胞測試，其24 hrs的 LD50約為100μg/cc。另做纖維母細胞(fibroblast)為正常細胞對照組，進行MTT 毒性測試，發現傷寒草莖葉氯仿萃取液之濃度對纖維母細胞(fibroblast)及口腔癌細胞(CT-5’)的毒性皆與濃度成正相關，但對纖維母細胞具較低的毒性。將不同濃度之傷寒草莖葉氯仿萃取液處理細胞24小時後，以D2O/PBS中的D置換細胞內的H，利用NMR儀器分析，觀察細胞內CH2及CH3於H’-NMR圖譜上之peak高度變化，peak的高度，可分別表示細胞CH2及CH3 的濃度。發現隨著細胞處理藥物的濃度的升高，H’-NMR圖譜上CH2/CH3高度比值隨之減低，顯示細胞內CH2/CH3內的濃度比值下降。由此實驗初步證明傷寒草莖葉氯仿萃取液引起口腔癌細胞(CT-5’)的死亡機制可能經由細胞程式死亡(apoptosis)。另將不同濃度傷寒草莖葉氯仿萃取液處理細胞24小時，以流式細胞儀(flow cytometry)進行分析，發現細胞隨著處理之傷寒草莖葉氯仿萃取液濃度增加，Sub-G1 peak越高，細胞內的DNA斷裂越多，此現象可能表示細胞apoptosis的現象越明顯。另外，利用acrydine orange將細胞內的染色體染色，觀察細胞加入藥物後的型態變化，發現未加藥物之細胞，細胞的型態完整。隨著藥物濃度的增加，細胞染色質濃縮現象越明顯，亦產生越多的凋亡細胞(apoptotic body)，且具dose-dependent的現象。由上證明傷寒草莖葉氯仿萃取液殺死口腔癌細胞(CT-5’)之途徑是經由細胞自殺性死亡(apoptosis)。

Abstract
The main purpose of the experiment is to explore the lethal effect of Vernonia cinerea to oral cancer cell line. We want to explore the lethal effect of the extracts from Vernoniaa cinerea to oral cancer cell line (CT-5’) in the essay. We also try to fine the possible mechanism of Vernonia cinerea to oral cancer cell line (CT-5’) with any kinda bio-assay methods. Vernonia cinerea, as known as composiate, a Chinese herb with purpose bloom, distributed in tropic Asia. People in Taiwan boiled it with rice wine and water to take and find that has its anticancer effect for both oral cancer and larynx cancer.
We extracted the Vernonia cinerea with 50% alcohol and concentrated by rotavapor .The LD50 in extracts of the whole plant of Vernonia cinerea to CT-5’ cell after 24hrs treatment was 375μg/cc.However,the chloroform phase extract from the aerial part of Vernonia cinerea after 50% alcohol extraction the LD50 was 100 μg/cc after 24hrs treatment. And keep the test of cytotoxicity by MTT assay as fibroblast as control. The chloroform phase extracts from the aerial part of Vernonia cinerea to CT-5’ and fibroblast was dose-dependent manner. But it had less cytotoxicity to fibroblast. We replace the H of CT-5'' with D from D2O/PBS after treating CT-5'' with different concentrations after 24hrs.According to the NMR result ,We find the ratio of the peak high in -CH2 and -CH3 on the H’-NMR spectrum that was dose-dependent with the ratio of the two peaks. With the increasing of the concentrations of the chloroform phase extracts from the aerial part of Vernonia cinerea ,the ratio of CH2/CH3 decrease in CT-5’ cell. What we mention above prove me the pathway might be by apoptosis in the effect of CT-5’ induced by chloroform phase extracts of the aerial part of Vernonia cinerea.The result show from cytometry after treating CT-5’ with different chloroform phase extracts .The Sub-G1 peak is does-dependent with the concentrations of the extracts that show the cleavage of the DNA in the cell is getting more and more .The phenomenon above may show the signal of apoptosis in the CT-5’ cell. In the other hand, we stained the chromosome of the cell with acrydine orange after treating cell with different concentrations of the chloroform phase extracts from the aerial part of Vernonia cinerea .We observe that morphology of the untreated cell is intact .The phenomenon of chromosome condensation and the forming of apoptotic bodies became more and more when we increased the concentrations of the extract to the cell. What phenomenon we observe above provide the possible pathway that the chloroform phase extracts from the aerial part of Vernonia cinerea in CT-5’ lethal effect might be by apoptosis.

章節目錄
中文摘要……………………………………………………i
英文摘要……………………………………………………iii
縮寫表………………………………………………………v
章節目錄……………………………………………………vi
表圖目錄……………………………………………………vii
前言…………………………………………………………1
材料與方法…………………………………………………7
結果…………………………………………………………20
討論...………………………………………………………29
圖表…………………………………………………………37
參考文獻……………………………………………………51

Reference
Adeboye J.O,Asij.W and Awe.S.O..Diuretic and antidiuretic of the leaf extracts of Vernonia cinere(less). (Fam.composite).Phyththerapy research. 11:454-6,1997
Ahmad M. Shi Y. TRAIL-induced apoptosis of thyroid cancer cells:potential for therapeutic intervention. Oncogene. 19:3363-71, 2000
Bernas T. Dobrucki JW. The role of plasma membrane In bioreduction of two tetrazolium salts, MTT, and CTC. Archives of Biochemistry & Biophysics. 380:108-16, 2000
Bratton DL. Fadok VA. Richter DA. Kailey JM. Frasch SC. Nakamura T.Henson PM. Polyamine regulation of plasma membrane phospholipid flip-flop during apoptosis. Journal of Biological Chemistry. 274:28113-20, 1999
Buhagiar JA. Podesta MT. Wilson AP. Micallef MJ. Ali S. The induction of apoptosis in human melanoma, breast and ovarian cancer cell lines using an essential oil extract from the conifer Tetraclinis articulata. Anticancer Research. 19:5435-43, 1999
Ceballos E. Delgado MD. Gutierrez P. Richard C. Muller D. Eilers M. Ehinger M. Gullberg U. Leon J. c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells. Oncogene. 19:2194-204, 2000
Champagne MJ. Dumas P. Orlov SN. Bennett MR. Hamet P Tremblay J. Protection against necrosis but not apoptosis by heat stress proteins in vascular smooth muscle cells: evidence for distinct modes of cell death . Hypertension,33:906-13,1999
Chang CC. Liu YC. Cleveland RP. Perkins SL. Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas. American Journal of Clinical Pathology. 113:512-8, 2000
Delehedde M. Cho SH. Sarkiss M. Brisbay S. Davies M. El-Naggar AK
McDonnell TJ. Altered expression of bcl-2 family member proteins in
nonmelanoma skin cancer. cancer 85:1514-22, 1999
Douglas R. Green and John C. Reed. Mitochondria and apoptosis. Science 281: 1309-12,1998
Ejima K. Koji T. Tsuruta D. Nanri H. Kashimura M. Ikeda M. Induction of apoptosis in placentas of pregnant mice exposed to lipopolysaccharides: possible involvement of Fas/Fas ligand system. Biology of Reproduction. 62:178-85,2000
Francic G.Blarkenberg,Peter D.Katsikis,Richard W.Storrs,Christian Beaulieu, Daniel Spielman,James Y.Chen,Louie Naumovski,and Jonathan F.Tait. Quantitative analysis of apoptoisis cell death using proton nuclear magnetic resonance spectroscopy. Blood.89: 3778-3786, 1997
Frankfurt OS. Byrnes JJ. Villa L. Protection from apoptotic cell death by interleukin-4 is increased in previously treated chronic lymphocytic leukemia patients [see comments]. Leukemia Research. 21:9-16, 1997
Gartner A. Milstein S. Ahmed S. Hodgkin J. Hengartner MO. A conserved checkpoint pathway mediates DNA damage--induced apoptosis and cell cycle arrest in C. elegans. Molecular Cell. 5:435-43, 2000
Harada J.Sugimoto M.An inhibitor of P38 and JNK MAP kinase prevents activation of caspase and apoptosis of cultured cerebellar granule neurons. Japanese Journal of Pharmacology.78:369-78,1999
Hayashi R. Ito Y. Matsumoto K. Fujino Y. Otsuki Y. Quantitative differentiation of both free 3''-OH and 5''-OH DNA ends between heat induced apoptosis and necrosis. Journal of Histochemistry & Cytochemistry. 46:1051-59, 1998
Herceg Z. Wang ZQ. Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis. Molecular & Cellular Biology. 19:5124-33, 1999
Honda M. Kaneko S. Shimazaki T. Matsushita E. Kobayashi K. Ping LH. Zhang HC. Lemon SM. Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. Hepatology. 31:1351-9, 2000
Hug H. Los M. Hirt W. Debatin KM. Rhodamine 110-linked amino acids and peptides as substrates to measure caspase activity upon apoptosis induction in intact cells. Biochemistry. 38:13906-11, 1999
Hsu SL. Yin SC. Liu MC. Reichert U. Ho WL. Involvement of cyclin -dependent kinase activities in CD437-induced apoptosis. Experimental Cell Research.252:332-41, 1999
Iohara N. Koseki T. Hu Y. Chen S. Nunez G. CLARP, a death effector domain- contInaining protein interacts with caspase-8 and regulates apoptosis. Proceedings of the National Academy of Sciences of the United States of America.94:10717-22, 1997
Jakupovic J.Banerjee S.Castro V.Bohlmann F.Schuster A.Msonthi J
D.Keeley S. Poskeanolide a seco-germacranolide and other sesquiterpene lactones from Vernonia cinerea. Phytochemistry 25:1359-64,1986
Jia L. Macey MG. Yin Y. Newland AC. Kelsey SM. Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis. Blood. 93:2353-9, 1999
J.O.Adeboye,W.Asij and S.O.Awe..Diuretic and antidiuretic of the leaf extractsof Vernonia cinere(less) .(Fam.composite).Phyththerapy research. 11:454-6,1997
Inohara N. Koseki T. Hu Y. Chen S. Nunez G. CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proceedings of the National Academy of Sciences of the United States of America.94:10717-22, 1997
Le MG. Mathieu MC. Douc-Rasy S. Le Bihan ML. Adb El All H.Spielmann M.Riou G. c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating Breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients. International Journal of Cancer. 84:562-7, 1999
Lee KK.Murakawa M.Takahashi S.Tsubuki S.Sakamaki K.Yonehara S.Proteolytic activation of MST/Krs,STE20-re;ated protein Kinase,by caspase during apoptosis.Oncogene.16:3029-37,1998
Lelli JL Jr. Becks LL. Dabrowska MI. Hinshaw DB. ATP converts necrosis to apoptosis in oxidant-injured endothelial cells. Free Radical Biology & Medicine. 25:694-702, 1998
Liu GY. Chen KJ. Lin-Shiau SY. Lin JK. Peroxyacetyl nitrate-induced apoptosis through generation of reactive oxygen species in HL-60 cells. Molecular Carcinogenesis. 25:196-206, 1999
Maecker HL. Koumenis C. Giaccia AJ. p53 promotes selection for Fas -mediated apoptotic resistance. Cancer Research. 60:4638-44, 2000
Misra Triguna. Singh Ram. Srivastava Ragini.Pandey Hari S.Prasad Chanda. Singh Satyendra. A new triterpenoid from Vernonia cinerea.Planta Media 59:458-460,1993
Nomura M. Shimizu S. Ito T. Narita M. Matsuda H. Tsujimoto Y. Apoptotic cytosol facilitates Bax translocation to mitochondria that involves cytosolic factor regulated by Bcl-2. Cancer Research. 59:5542-8, 1999
O’Donnell V.B.,Spycher S., and Azzi A.:Involvement of oxidants and oxidant-generation enzyme(s) in tumour-necrosis-factor-medianted apoptosis:role for li[pxygenase pathway but not mitochondrial respiratory chain.Biochemical Journal,310:133-141,1995
Ray R. Chen G. Vande Velde C. Cizeau J. Park JH. Reed JC. Gietz RD.
Greenberg AH. BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. Journal of Biological Chemistry. 275:1439-48, 2000
Senogles SE. The D2s dopamine receptor stimulates phospholipase D activity: a novel signaling pathway for dopamine. Molecular Pharmacology. 58:455-62,2000
Verneris MR. Kornacker M. Mailander V. Negrin RS. Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis. Cancer Immunology, Immunotherapy. 49:335-45, 2000
Wyllie A. H.:Glucocorticoid-induced thmocyte apoptosis is associated with endogenous endonuclease activation.Nature,284:555-556,1980
Yang B. Gu F. Wang X. [Expression of the bcl-2 and bax oncoprotein in
TCC and its clinical significances]. [Chinese] Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery]. 35:602-4, 1997
Yao PM. Tabas I. Free cholesterol listry. 275:23807-13,2000
Zhang Yuxiang, Arun K.Rishi, Moading of macrophages induces apoptosis involving the fas pathway. Journal of Biological Chemarcia I.Dawson,rainbow Tschang,Lulu, Farhana,Madanamohan Boyanapalli, Uwe Reichert, Braham Shroot,EricC.Van Buren,and Joseph A.Fontana. S-phase arrest and apoptosis induce in normal Mammary pitheial cells by a vovel retinoid.Cancer Research 60:2025-2032,2000
李育浩.吳清和.李茹柳.韓堅.陸海.陳建雄. 傷寒草藥理研究 中藥材16:31-33,1993
李勉民 常見藥草圖說p346,1999
邱年永,張光雄 原色台灣藥用植物圖鍵 (1) p229,1999
張又強(a) 700-治癌中要秘方 p22-p26,1992
張又強(b) 700-治癌中要秘方 p108-p110,1992
張又強(c) 700-治癌中要秘方p181-p183,1992
陶聲洋防癌基金會編輯 治癌機先p38-p44,193
顏道銘 癌症綜合藥論 p8,1993